Pura Vida Investments, LLC Viridian Therapeutics, Inc.\De Transaction History

Pura Vida Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$18.78 - $29.74 $751,200 - $1.19 Million	-40,000 Reduced 53.33%	35,003 $1.02 Million
Q3 2022 Nov 14, 2022	SELL	$10.7 - $25.5 $325,889 - $776,653	-30,457 Reduced 28.88%	75,003 $1.54 Million
Q1 2022 May 16, 2022	BUY	$16.79 - $20.88 $10,074 - $12,528	600 Added 0.57%	105,460 $1.95 Million
Q4 2021 Feb 14, 2022	BUY	$15.65 - $21.5 $731,856 - $1.01 Million	46,764 Added 80.49%	104,860 $2.07 Million
Q3 2021 Nov 15, 2021	BUY	$10.69 - $18.2 $621,046 - $1.06 Million	58,096 New	58,096 $956,000

179

76.6M

581K

439K

Ticker VRDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,888,900
Market Cap $805M
Description
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.